Authors
Yaru Zhao, Hao Shi, Wei Zhang, Kongzheng Li, Gangqiang Lin, Yafang Chen, Xiaotong Lin, Xiaoshan Zhao, Huijie Fan
Published in
Journal of ethnopharmacology. Pages 122622. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
Hyperlipidemia (HL) is a major cardiovascular risk factor that can induce early endothelial dysfunction and compromise vascular endothelial barrier integrity. Danggui-Shaoyao-San (DSS), a traditional Chinese herbal formula, has shown potential vascular protective effects. However, the circulating DSS-associated constituents and molecular pathways potentially involved in its protective effects against HL-induced endothelial barrier dysfunction remain incompletely understood.
ApoE-/- mice fed a high-fat diet (HFD) were used to establish a model of HL-associated vascular endothelial barrier injury and to evaluate the effects of different doses of DSS. UPLC-Q-TOF-MS was used to characterize DSS-associated constituents detected in serum. Metabolic parameters, inflammatory markers, vascular permeability, aortic histopathology, endothelial ultrastructure, and junctional protein expression were evaluated. Transcriptomic analysis and molecular docking were integrated to explore potential targets and signaling pathways. Surface plasmon resonance (SPR) was subsequently performed to evaluate the direct binding of representative serum constituents to RAP1B. Rap1-GTP pull-down, Western blotting, and immunofluorescence analyses were further used to assess Rap1 activation, PI3K/AKT phosphorylation, and endothelial junctional proteins.
Mass spectrometry enabled the putative annotation of 19 DSS-associated serum constituents. DSS treatment alleviated HFD-induced metabolic derangements and systemic inflammation, reduced aortic permeability, and preserved endothelial morphology and junctional integrity. Transcriptomic analysis and molecular docking analyses highlighted Ras-related protein 1 (Rap1) and PI3K/AKT-related signaling for subsequent experimental investigation. SPR analysis revealed concentration-dependent binding of paeoniflorin, albiflorin, and ligustilide to RAP1B, with apparent dissociation constants (K_D) of 4.158, 4.240, and 28.71 μM, respectively. Rap1 activation, quantified as the GTP-Rap1/total Rap1A/1B ratio, was reduced in the HFD model group and increased following DSS treatment. The DSS-associated increase in Rap1 activation were accompanied by increased PI3K and AKT phosphorylation and expression of endothelial junctional proteins, including ZO-1, occludin, claudin-1, and VE-cadherin.
DSS alleviated HL-associated vascular endothelial barrier dysfunction in HFD-fed ApoE-/- mice, accompanied by improvements in metabolic homeostasis and preservation of endothelial junctional integrity. The in vitro binding of selected serum constituents to recombinant RAP1B, together with restored Rap1 activation and increased PI3K/AKT phosphorylation, is consistent with the potential involvement of Rap1-associated signaling in the vascular protective effects of DSS. These findings provide preclinical evidence supporting further investigation of DSS for hyperlipidemia-associated vascular injury.
PMID:
43034027
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0